HERZLIYA, Israel and CALGARY, Alberta, July 23, 2025 /PRNewswire/ — Innocan Pharma Corporation (“Innocan” or the “Company“) (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has publicly filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission (the “SEC“) relating to a proposed public offering of units […]
SAN DIEGO, July 23, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that the RxSight class action lawsuit – captioned Makaveev v. RxSight, Inc., No. 25-cv-01596 (C.D. Cal.) – seeks to represent purchasers or acquirers of RxSight, Inc. (NASDAQ: RXST) securities and charges certain of RxSight’s top executives with
NEWTOWN, Pa., July 23, 2025 /PRNewswire/ — Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Encompass Health Corporation (“Encompass”) (NYSE: EHC), resulting from allegations of providing potentially misleading information to the investing public. If you are an Encompass investor who suffered a substantial loss and would like to learn more, you can
NASDAQ | TSX: ACB EDMONTON, AB, July 23, 2025 /PRNewswire/ – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2026 on Wednesday, August 6,
Aurora Cannabis to Host First Quarter 2026 Investor Conference Call Read Post »
PressClaudin 18.2-directed therapies are on track to become foundational in the treatment of gastrointestinal and select solid tumors. Fueled by innovation in antibody engineering, combination strategies, and biomarker testing, this therapeutic class is set to play a transformative role in the next generation of precision oncology. LAS VEGAS, July 23, 2025 /PRNewswire/ — DelveInsight’s Claudin
MEXICO CITY, July 23, 2025 /PRNewswire/ — Grupo Rotoplas S.A.B. de C.V. (BMV: AGUA*) (“Rotoplas”, “the Company”), the leading provider of water solutions in the Americas, today reports its unaudited financial results for the second quarter of 2025. The information has been prepared in accordance with International Financial Reporting Standards (IFRS). Figures are expressed in
Rotoplas: Second Quarter 2025 Results Read Post »
Press
New Funding Opportunity Seeks Catalytic Solutions to Address Data Demand SAN DIEGO, July 23, 2025 /PRNewswire/ — Cambiar Education, with support from the Walton Family Foundation, Bezos Family Foundation, and Lemnis, today announced the launch of the Thrive Big Ideas Challenge, a national competition designed to catalyze transformative solutions that empower students and caregivers with
NEEDHAM, Mass., July 23, 2025 /PRNewswire/ — NB Bancorp, Inc. (the “Company”) (Nasdaq Capital Market: NBBK), the holding company of Needham Bank (the “Bank”), today announced its second quarter 2025 financial results. The Company reported net income of $14.6 million, or $0.39 per diluted common share, compared to net income of $12.7 million, or $0.33
